Cardiopulmonary Stress Testing Systems Market By Product Type (Cardiopulmonary Exercise Testing Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography), By End-User Segment (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic and Cardiology Centers) - Growth, Future Prospects, and Competitive Analysis, 2019 - 2027
"Cardiopulmonary stress testing systems market to exhibit dynamic growth during the forecast period"
The global cardiopulmonary stress testing systems market is growing efficiently, expected to grow at a CAGR of 4.8%. Globally, growing diagnostic procedures for cardiovascular-related disorders such as heart valve imbalance and arrhythmia will drive market growth. Increasing awareness about new lifestyle diseases along with heart and lung disorders are factors driving the overall growth of cardiopulmonary stress testing systems market globally. Other major factors include development in the portable device industry, invention of high sensitivity ECG devices, growth in the cardiovascular centers for enhanced diagnostics and new technology expansion in the emerging nations at low cost.
"Cardiopulmonary exercise testing systems segment expected to register higher growth by the end of 2027"
Advancement in cardiac diagnostic testing along with the development in the field of echocardiograph testing devices and exercise tolerance testing devices will enhance the overall demand. Cardiopulmonary exercise (CPX) testing devices will show promising growth on a global scale. Increasing trend for wireless devices is expanding significantly, has the capability to detect specific conditions related to heart or lungs along with smart features. For e.g. K5 wearable metabolic systems (COSMED), Orbit-K Blood Pressure Cuff, Oxycon mobile cardiopulmonary stress testing and others. The global manufacturers are focusing on new product launch and further R&D for commercialization of these testing systems to meet the active demand in the near future.
"Diagnostic and cardiology centers to witness a significant CAGR"
The higher average selling price of stress testing systems, increasing adoption of new products along with its services provided at cardiac centers and increasing preference for portable cardiopulmonary testing systems on a global scale are prominent factors expected for the growth of the market. Hospitals generated maximum revenue share in 2018, due to the large patient pool and increasing preference of hospital physicians as well as individuals for the early diagnosis of cardiovascular-related diseases. Higher demand in the developing nations, product expansion and awareness for enhanced outcomes will drive the market growth in the end-user segment globally.
"Increasing population, new FDA approval and the presence of top manufacturers hold North America in dominant position"
In 2018, the U.S. generated maximum revenue share in the cardiopulmonary stress testing systems market due to an increase in prevalence for lifestyle disorders, rising hospitals admissions and launch of new stress testing systems. Growing adoption of early cardiopulmonary diagnosis practices, increased patient pool in the U.S. and Canada, increasing adoption and penetration of advanced testing systems at public health centers/institutes which aid nurses and hospital physicians for patient health monitoring in real-time are major factors driving the growth in North America. To upsurge economical edge globally, top manufacturers have concentrated on the procedure of partnerships & collaborations, adoption of new techniques and launch of medical technology products. However, the higher expense of software-based arrangements, less popularity among the physicians, complexity in R&D, and constrained returns may hinder the market growth during the forecast period.
"Increased research and development with strong product pipelines in the developed regions"
Major players in the cardiopulmonary stress testing systems market are GE Healthcare, Thermo Fisher Scientific Ltd., Cardinal Health, Cosmed Medical, Spacelabs Healthcare, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, Vyaire Medical Inc., Hill-Rom Holdings Inc., Masimo, MGC Diagnostics Corporation, Schiller AG, MGC Diagnostics Corporation and others. Major top organizations and are emerging with smart technologies with integrated software systems. Partnerships acquisitions and improved R&D on medical equipment will improvise the development of cardiopulmonary stress testing systems market in the developing nations in the near future.
Historical & Forecast Period
This study report represents analysis for each segment from 2017 to 2027 considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.
Report Scope by Segments
Market Segmentation: Global Cardiopulmonary Stress Testing Systems Market
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2017-2027 |
| Base Year | 2018 |
| Forecast Period | 2019-2027 |
| Historical Year | 2017 |
| Unit | USD Million |
| Segmentation |
Product Type (2017–2027; US$ Mn) |
|
End-User Segment (2017–2027; US$ Mn) |
|
|
Geography Segment (2017–2027; US$ Mn) |
The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that give a better market understanding of the overall cardiopulmonary stress testing systems market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.
Key questions answered in this report
- What are the current market trends and dynamics in the cardiopulmonary stress testing systems market and valuable opportunities for emerging players?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which product type segment holds a larger market share and why?
- Are low and middle-income economies investing in the cardiopulmonary stress testing systems market?
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global CSTS Market Portraiture
2.2. Global CSTS Market, By Product Type, 2018 (US$ Mn)
2.3. Global CSTS Market, By End User, 2018 (US$ Mn)
2.4. Global CSTS Market, by Geography, 2018 vs. 2027 (Value %)
Chapter 3. Global Cardiopulmonary Stress Testing Systems (CSTS) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. CSTS Market Technologies: Future Trends
3.3. Current Scenario: New Product Launches, High Prevalence For Cardiovascular Disease
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2018
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2018
Chapter 4. Global Cardiopulmonary Stress Testing Systems (CSTS) Market, by Product Type, 2017 – 2027 (US$ Mn)
4.1. Overview
4.2. Cardiopulmonary Exercise Testing (CPET) Systems
4.3. Stress ECG
4.4. Pulse Oximeters
4.5. Stress Blood Pressure Monitors
4.6. Single-Photon Emission Computed Tomography (SPECT)
Chapter 5. Global Cardiopulmonary Stress Testing Systems (CSTS) Market, By End User, 2017 – 2027 (US$)
5.1. Overview
5.2. Hospitals
5.3. Specialty Clinics
5.4. Ambulatory Surgical Centers
5.5. Diagnostic and Cardiology Centers
Chapter 6. Global Cardiopulmonary Stress Testing Systems (CSTS) Market, by Geography, 2017 – 2027 (US$ Mn)
6.1. Overview
6.2. North America CSTS Market Analysis, 2017 – 2027
6.2.1. North America CSTS Market, By Product Type, 2017 – 2027 (US$ Mn)
6.2.2. North America CSTS Market, By End User, 2017 – 2027 (US$ Mn)
6.2.3. North America CSTS Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe CSTS Market Analysis, 2017 – 2027
6.3.1. Europe CSTS Market, By Product Type, 2017 – 2027 (US$ Mn)
6.3.2. Europe CSTS Market, By End User, 2017 – 2027 (US$ Mn)
6.3.3. Europe CSTS Market, by Country, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific CSTS Market Analysis, 2017 – 2027
6.4.1. Asia Pacific CSTS Market, By Product Type, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific CSTS Market, By End User, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific CSTS Market, by Country, 2017 – 2027 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America CSTS Market Analysis, 2017 – 2027
6.5.1. Latin America CSTS Market, By Product Type, 2017 – 2027 (US$ Mn)
6.5.2. Latin America CSTS Market, By End User, 2017 – 2027 (US$ Mn)
6.5.3. Latin America CSTS Market, by Country, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) CSTS Market Analysis, 2017 – 2027
6.6.1. MEA CSTS Market, by Product Type, 2017 – 2027 (US$ Mn)
6.6.2. MEA CSTS Market, By End User, 2017 – 2027 (US$ Mn)
6.6.3. MEA CSTS Market, by Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. GE Healthcare
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Thermo Fisher Scientific Ltd.
7.3. Cardinal Health
7.4. Cosmed Medical
7.5. Spacelabs Healthcare
7.6. Koninklijke Philips N.V.
7.7. NIHON KOHDEN CORPORATION
7.8. Vyaire Medical Inc.
7.9. Hill-Rom Holdings Inc.
7.10. Masimo
7.11. MGC Diagnostics Corporation
7.12. Schiller AG
7.13. MGC Diagnostics Corporation
* Here we are using CSTS as a short form of Cardiopulmonary Stress Testing Systems
TABLE 1 Market Snapshot: Global Cardiopulmonary Stress Testing Systems (CSTS) Market
TABLE 2 Global CSTS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 3 Global CSTS Market, by End User, 2017–2027 (US$ Mn)
TABLE 4 Global CSTS Market, by Geography, 2017–2027 (US$ Mn)
TABLE 5 North America CSTS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 6 North America CSTS Market, by End User, 2017–2027 (US$ Mn)
TABLE 7 North America CSTS Market, by Country, 2017–2027 (US$ Mn)
TABLE 8 Europe CSTS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 9 Europe CSTS Market, by End User, 2017–2027 (US$ Mn)
TABLE 10 Europe CSTS Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 11 Latin America CSTS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 12 Latin America CSTS Market, by End User, 2017–2027 (US$ Mn)
TABLE 13 Latin America CSTS Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 14 Asia Pacific CSTS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 15 Asia Pacific CSTS Market, by End User, 2017–2027 (US$ Mn)
TABLE 16 Asia Pacific CSTS Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 17 Middle East & Africa CSTS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 18 Middle East & Africa CSTS Market, by End User, 2017–2027 (US$ Mn)
TABLE 19 Middle East & Africa CSTS Market, by Region, 2017–2027 (US$ Mn)
TABLE 20 GE Healthcare.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Thermo Fisher Scientific Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Cardinal Health: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 Cosmed Medical: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Spacelabs Healthcare: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Koninklijke Philips N.V.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 NIHON KOHDEN CORPORATION: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Vyaire Medical Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Hill-Rom Holdings Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Masimo: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 MGC Diagnostics Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Schiller AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 MGC Diagnostics Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
FIG. 1 Global Cardiopulmonary Stress Testing Systems (CSTS) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global CSTS Market Segmentation
FIG. 4 Global CSTS Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global CSTS Market, by End User, 2017 (US$ Mn)
FIG. 6 Global CSTS Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key CSTS Market Manufacturers, 2018
FIG. 9 Global CSTS Market for Cardiopulmonary Exercise Testing (CPET) Systems, 2017–2027 (US$ Mn)
FIG. 10 Global CSTS Market for Stress ECG, 2017–2027 (US$ Mn)
FIG. 11 Global CSTS Market for Pulse Oximeters, 2017–2027 (US$ Mn)
FIG. 12 Global CSTS Market for Stress Blood Pressure Monitors, 2017–2027 (US$ Mn)
FIG. 13 Global CSTS Market for Single-Photon Emission Computed Tomography (SPECT), 2017–2027 (US$ Mn)
FIG. 14 Global CSTS Market for Hospitals, 2017–2027 (US$ Mn)
FIG. 15 Global CSTS Market for Specialty Clinics, 2017–2027 (US$ Mn)
FIG. 16 Global CSTS Market for Ambulatory Surgical Centers, 2017–2027 (US$ Mn)
FIG. 17 Global CSTS Market for Diagnostic and Cardiology Centers, 2017–2027 (US$ Mn)
FIG. 18 U.S. CSTS Market, 2017–2027 (US$ Mn)
FIG. 19 Canada CSTS Market, 2017–2027 (US$ Mn)
FIG. 20 U.K. CSTS Market, 2017–2027 (US$ Mn)
FIG. 21 Germany CSTS Market, 2017–2027 (US$ Mn)
FIG. 22 Rest of Europe CSTS Market, 2017–2027 (US$ Mn)
FIG. 23 Japan CSTS Market, 2017–2027 (US$ Mn)
FIG. 24 China CSTS Market, 2017–2027 (US$ Mn)
FIG. 25 Rest of Asia Pacific CSTS Market, 2017–2027 (US$ Mn)
FIG. 26 Brazil CSTS Market, 2017–2027 (US$ Mn)
FIG. 27 Mexico CSTS Market, 2017–2027 (US$ Mn)
FIG. 28 Rest of Latin America CSTS Market, 2017–2027 (US$ Mn)
FIG. 29 GCC CSTS Market, 2017–2027 (US$ Mn)
FIG. 30 Rest of Middle East & Africa CSTS Market, 2017–2027 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)